Successful Management of Pregnancy with Severe Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor
Sajida Kazi(University of Edinburgh), Nadine Shehata(Mount Sinai Hospital), Lynda Harrington(Mount Sinai Hospital), Ann Kinga Malinowski(Mount Sinai Hospital), Nancy Watts(Mount Sinai Hospital), Chen Wang(National Institutes of Health), Kevin H.M. Kuo(University Health Network), Clare Whitehead(Mount Sinai Hospital)
Cited by 4
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Alcohol consumption and risks of more than 200 diseases in Chinese men
|Nature Medicine|2023|188
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162